Dutch biopharma Kiadis Pharma (Euronext: KDS) today announced senior management appointments to further strengthen the company as it transitions into commercial stage.
Dirk de Naeyer, who joined Kiadis Pharma in October 2018 as head of supply chain, moves to the position of chief operations officer, as a planned succession from Jan Feijen. Prior to joining Kiadis, Mr de Naeyer was at Janssen Pharmaceuticals where he spent 14 years in various leadership positions.
Martine Nolan joins the company as head of quality assurance. Ms Nolan brings over 20 years of experience in the pharmaceutical sector to Kiadis which she joins from Amgen (Nasdaq: AMGN), where she served as regional head of quality operations, leading a team of more than 200 employees at the Dublin, Ireland and Breda, Netherlands sites. Prior to that Ms Nolan served as executive director for international quality, Turkey, Middle East & Africa where she had responsibility for quality of both manufacturing and distribution activities at Amgen.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze